A candidate multi-epitope vaccine against SARS-CoV-2
T Kar, U Narsaria, S Basak, D Deb, F Castiglione… - Scientific reports, 2020 - nature.com
In the past two decades, 7 coronaviruses have infected the human population, with two
major outbreaks caused by SARS-CoV and MERS-CoV in the year 2002 and 2012 …
major outbreaks caused by SARS-CoV and MERS-CoV in the year 2002 and 2012 …
Vaccination against β-Amyloid as a Strategy for the Prevention of Alzheimer's Disease
F Mantile, A Prisco - Biology, 2020 - mdpi.com
Simple Summary Immunization against β-amyloid has been explored as a vaccination
strategy for Alzheimer's disease for over 20 years. No vaccine has been licensed so far, and …
strategy for Alzheimer's disease for over 20 years. No vaccine has been licensed so far, and …
Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach
Ongoing COVID-19 outbreak has raised a drastic challenge to global public health security.
Most of the patients with COVID-19 suffer from mild flu-like illnesses such as cold and fever; …
Most of the patients with COVID-19 suffer from mild flu-like illnesses such as cold and fever; …
Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches
SARS-CoV-2 causes a severe respiratory disease called COVID-19. Currently, global health
is facing its devastating outbreak. However, there is no vaccine available against this virus …
is facing its devastating outbreak. However, there is no vaccine available against this virus …
Immunoinformatics design of a novel epitope-based vaccine candidate against dengue virus
AO Fadaka, NRS Sibuyi, DR Martin, M Goboza… - Scientific reports, 2021 - nature.com
Dengue poses a global health threat, which will persist without therapeutic intervention.
Immunity induced by exposure to one serotype does not confer long-term protection against …
Immunity induced by exposure to one serotype does not confer long-term protection against …
Immunoinformatics-guided designing of epitope-based subunit vaccine from Pilus assembly protein of Acinetobacter baumannii bacteria
Acinetobacter baumannii, a prominent pathogen responsible for chronic infections in the
blood, urinary tract, and lungs, has a high mortality due to its virulence and limited …
blood, urinary tract, and lungs, has a high mortality due to its virulence and limited …
Designing a multi-epitope vaccine candidate to combat MERS-CoV by employing an immunoinformatics approach
Currently, no approved vaccine is available against the Middle East respiratory syndrome
coronavirus (MERS-CoV), which causes severe respiratory disease. The spike glycoprotein …
coronavirus (MERS-CoV), which causes severe respiratory disease. The spike glycoprotein …
Durable CD8 T cell memory against SARS-CoV-2 by Prime/Boost and multi-dose vaccination: Considerations on inter-dose time intervals
A Natalini, S Simonetti, C Sher, U D'Oro… - International Journal of …, 2022 - mdpi.com
Facing the COVID-19 pandemic, anti-SARS-CoV-2 vaccines were developed at
unprecedented pace, productively exploiting contemporary fundamental research and prior …
unprecedented pace, productively exploiting contemporary fundamental research and prior …
Designing of a next generation multiepitope based vaccine (MEV) against SARS-COV-2: Immunoinformatics and in silico approaches
Coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory
coronavirus 2 (SARS-COV-2) is a significant threat to global health security. Till date, no …
coronavirus 2 (SARS-COV-2) is a significant threat to global health security. Till date, no …
Designing a multi-epitope peptide based vaccine against SARS-CoV-2
COVID-19 pandemic has resulted in 16,114,449 cases with 646,641 deaths from the 217
countries, or territories as on July 27th 2020. Due to multifaceted issues and challenges in …
countries, or territories as on July 27th 2020. Due to multifaceted issues and challenges in …